mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
To deepen our knowledge about circ-ZNF609 role in cell cycle regulation, we studied its expression and function in rhabdomyosarcoma (RMS), a pediatric skeletal muscle malignancy.
|
30670781 |
2019 |
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma.
|
30478938 |
2019 |
Colorectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Circ-ZNF609 expression in colorectal cancer tissues and mucosa tissues were detected by quantitative real-time PCR (qRT-PCR).
|
30570857 |
2019 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Circ-ZNF609 expression in GC tissues and adjacent normal tissues (ANT) was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR).
|
31773689 |
2019 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
|
31002133 |
2019 |
Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We found that circ-ZNF609 is upregulated in biopsies from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS).
|
30670781 |
2019 |
Childhood Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We found that circ-ZNF609 is upregulated in biopsies from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS).
|
30670781 |
2019 |
Adult Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We found that circ-ZNF609 is upregulated in biopsies from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS).
|
30670781 |
2019 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Circ-ZNF609 promotes carcinogenesis of gastric cancer cells by inhibiting miRNA-145-5p expression.
|
31773689 |
2019 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Circ-ZNF609 expression in GC tissues and adjacent normal tissues (ANT) was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR).
|
31773689 |
2019 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
To deepen our knowledge about circ-ZNF609 role in cell cycle regulation, we studied its expression and function in rhabdomyosarcoma (RMS), a pediatric skeletal muscle malignancy.
|
30670781 |
2019 |
Renal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma.
|
30478938 |
2019 |
Nasopharyngeal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Circ-ZNF609 expression was silenced in NPC cell lines (5-8F and HONE-1).
|
31002133 |
2019 |
MYOTONIC DYSTROPHY 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, increased circular fractions of RTN4_03 and ZNF609 were also observed in differentiated myogenic cell lines derived from DM1 patients.
|
31010208 |
2019 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Circ-ZNF609 expression in colorectal cancer tissues and mucosa tissues were detected by quantitative real-time PCR (qRT-PCR).
|
30570857 |
2019 |
Hirschsprung Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, these findings illustrated that cir-ZNF609 took part in the onset of HSCR through the crosstalk with AKT3 by competing for shared miR-150-5p.
|
27903978 |
2017 |
Endothelial dysfunction
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Silencing Of Circular RNA-ZNF609 Ameliorates Vascular Endothelial Dysfunction.
|
28824721 |
2017 |